Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly selective PDE10A inhibitor via core structure transformation from the stilbene moiety

Add time:08/12/2019    Source:sciencedirect.com

We have developed a new class of PDE10A inhibitor, a pyrazolo[1,5-a]pyrimidine derivative MT-3014 (1). A previous compound introduced was deprioritized due to concerns for E/Z-isomerization and glutathione-adduct formation at the core stilbene structure. We discovered pyrazolo [1,5-a] pyrimidine as a new lead scaffold by structure-based drug design utilizing a co-crystal structure with PDE10A. The lead compound was optimized for in vitro activity, solubility, and selectivity against human ether-á-go-go related gene cardiac channel binding. We observed that MT-3014 shows excellent efficacy in rat conditioned avoidance response test and suitable pharmacokinetic properties in rats, especially high brain penetration.

We also recommend Trading Suppliers and Manufacturers of Pyrazolo[1,5-a]pyridine-3,7-diol (cas 135455-76-4). Pls Click Website Link as below: cas 135455-76-4 suppliers

Prev:Solution state conformation of an immunosuppressive cyclic dodecapeptide, cycloleonurinin (cas 135447-56-2)☆
Next:Strontium ranelate (cas 135459-87-9) increases osteoblast activity)